KALA Financials

Kala Pharmaceuticals Inc - Financial statements & key metrics

Stock Price

$0.53

Market Cap

$54.28M

P/E Ratio

-0.2

EPS

$-5.64

Income Statement Highlights

Most Recent Quarter: FY

Revenue

-

Gross Profit

-

Operating Income

$-39.16M

Net Income

$-26.98M

EPS (Diluted)

$-3.31

Balance Sheet Highlights

Total Assets

$9.49M

Total Liabilities

$2.49M

Shareholders Equity

$7.00M

Cash & Equivalents

$7.56M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-31.99M

CapEx

-

Free Cash Flow

-

Profitability Metrics

00

ROE

-708.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is KALA revenue?

View KALA's income statement for detailed revenue data.

Is KALA profitable?

KALA reported a loss of $26.98M in the most recent quarter.

What is KALA market cap?

KALA has a market capitalization of $54.28M, making it a small-cap stock.

Does KALA have debt?

View KALA's balance sheet for debt information.

What is KALA cash flow?

Cash flow data is available in the full financial statements.

Explore Categories